Hayao

Business focus

MedTech, BioTech & Pharma

Description

Harbin Pharmaceutical Group (Hayao) was founded on 28 December 1991 in Harbin, Heilongjiang, becoming China's first publicly listed pharmaceutical company (Shanghai Stock Exchange, 1993, ticker 600664) and the first listed company from Heilongjiang Province. It is a state-controlled Sino-foreign joint venture spanning antibiotics, OTC/health products, modern TCM, biologics and raw materials; trailing revenue has been reported around $1.4-1.5 billion in recent years.